-
ENDRA Life Sciences Submits 510(k) Application to the US FDA for TAEUS(R) Liver Device
Jun 30, 2020
Regulatory submission marks another major step toward commercialization of TAEUS liver device in 2020...read more > -
ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents
Jun 23, 2020
Two Newly Issued Patents Further Protect ENDRA's TAEUS Platform Capabilities...read more > -
ENDRA Life Sciences to Present at the 2020 Virtual Summer Summit
Jun 8, 2020
ANN ARBOR, MI / ACCESSWIRE / June 8, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that management will present...read more > -
ENDRA Life Sciences Announces New Clinical Study Partnership with the Medical College of Wisconsin (MCW)
Jun 8, 2020
Study to Bolster Clinical Evidence of Performance of Patented TAEUS Ultrasound Device in NAFLD Patients as Commercialization Begins ...read more > -
47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th
Jun 3, 2020
NEW YORK, NY / ACCESSWIRE / June 3, 2020 / The Virtual Summer Summit will take place on June 9th-12th, connecting 47 presenting small and microcap companies with distinguished investors from around t...read more > -
ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results
May 14, 2020
ANN ARBOR, MI / ACCESSWIRE / May 14, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today provided a business update and re...read more > -
ENDRA Life Sciences Strengthens IP Portfolio with Issuance of Additional Patents for its Innovative Fatty Liver Imaging Probe
May 6, 2020
ANN ARBOR, MI / ACCESSWIRE / May 6, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), has recently been issued design patents D883...read more > -
ENDRA Life Sciences to Host First Quarter 2020 Financial Results Conference Call and Webcast on Thursday, May 14, 2020 at 4:30 p.m. ET
May 1, 2020
ANN ARBOR, MI / ACCESSWIRE / May 1, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its first quarter financi...read more > -
ENDRA Life Sciences Builds on CE Mark Approval
Apr 30, 2020
The pioneer of Thermo Acoustic Enhanced UltraSound advances its commercialization plan and intellectual property portfolio and reaffirms guidance to file 510(k) application with the FDA ...read more > -
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
Apr 13, 2020
ANN ARBOR, MI / ACCESSWIRE / April 13, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced a series of proactive measures t...read more >
